GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MedMen Enterprises Inc (OTCPK:MMNFF) » Definitions » EV-to-Revenue

MedMen Enterprises (MedMen Enterprises) EV-to-Revenue : 3.09 (As of May. 02, 2024)


View and export this data going back to 2018. Start your Free Trial

What is MedMen Enterprises EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, MedMen Enterprises's enterprise value is $371.6 Mil. MedMen Enterprises's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 was $120.1 Mil. Therefore, MedMen Enterprises's EV-to-Revenue for today is 3.09.

The historical rank and industry rank for MedMen Enterprises's EV-to-Revenue or its related term are showing as below:

MMNFF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0   Med: 0   Max: 0
Current: 3.09

MMNFF's EV-to-Revenue is not ranked
in the Drug Manufacturers industry.
Industry Median: 2.36 vs MMNFF: 3.09

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-02), MedMen Enterprises's stock price is $1.0E-6. MedMen Enterprises's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 was $0.09. Therefore, MedMen Enterprises's PS Ratio for today is 0.00.


MedMen Enterprises EV-to-Revenue Historical Data

The historical data trend for MedMen Enterprises's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedMen Enterprises EV-to-Revenue Chart

MedMen Enterprises Annual Data
Trend Oct13 Oct14 Oct15 Oct16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only -228,080.60 5.39 1.67 1.14 -0.05

MedMen Enterprises Quarterly Data
Apr18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.76 -0.05 -0.59 -0.82 -0.75

Competitive Comparison of MedMen Enterprises's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, MedMen Enterprises's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedMen Enterprises's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MedMen Enterprises's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where MedMen Enterprises's EV-to-Revenue falls into.



MedMen Enterprises EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

MedMen Enterprises's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=371.572/120.132
=3.09

MedMen Enterprises's current Enterprise Value is $371.6 Mil.
MedMen Enterprises's Revenue for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $120.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMen Enterprises  (OTCPK:MMNFF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

MedMen Enterprises's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=1.0E-6/0.092
=0.00

MedMen Enterprises's share price for today is $1.0E-6.
MedMen Enterprises's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedMen Enterprises EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of MedMen Enterprises's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


MedMen Enterprises (MedMen Enterprises) Business Description

Traded in Other Exchanges
Address
10115 Jefferson Boulevard, Culver City, CA, USA, 90232
MedMen Enterprises Inc formerly known as Ladera Ventures Corp is the preeminent cannabis company with multiple assets and operations in California, Nevada, and New York, which combined account for nearly half of North America's addressable legal market. The company owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail.

MedMen Enterprises (MedMen Enterprises) Headlines

From GuruFocus

MedMen Extends Maturity Date of Commercial Loan Agreement

By Business Wire Business Wire 02-02-2022

MedMen Announces Resignation of Chief Financial Officer

By Business Wire Business Wire 06-16-2023

MedMen Promotes Tyson Rossi to Chief Strategy Officer

By Business Wire Business Wire 01-25-2022

MedMen Announces Cannasseur Personal Concierge Service

By Business Wire Business Wire 02-01-2022

MedMen Provides Annual Filing Status Report

By Business Wire 11-30-2023